HIGHLIGHTS
- who: March and colleagues from the The University of Texas at El Paso, United States have published the Article: Nanomedicine in Lung Cancer Immunotherapy, in the Journal: (JOURNAL)
- future: More research is needed to fully understand the potential of this approach and to develop safe and effective nanomedicine-based immunotherapies for clinical use (Chen et_al 2020 Chauhan et_al 2021 Jin et_al 2021 Wang et_al 2022). chemotherapy.
SUMMARY
Chemotherapy has low specificity, drug-induced side effects, and drug resistance, and has shown higher cancer relapse rates similar to radiation therapy (Velpurisiva et_al . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.